AI-generated summary
The authors studied photobiomodulation therapy, using an 830 nm diode laser applied to the quadriceps, in mdx mice, a model of Duchenne muscular dystrophy, during the acute phase of disease. They report reduced degenerative and regenerative areas, changes in regenerative, oxidative, inflammatory and angiogenic markers, and effects similar to prednisolone in most parameters. The study was conducted in mice, so results may not apply to humans.
- Who or what was studied
- mdx mice (experimental model of Duchenne muscular dystrophy) and normal wild-type C57BL/10 control mice
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report sample sizes or human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species, Oxidative stress, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.